NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
Binbing Yu
AstraZeneca, Sweden - Södertälje / Sweden
Others
AD Scientific Index ID: 4400042
-
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Binbing Yu's MOST POPULAR ARTICLES
1-)
Red cell distribution width and mortality in older adults: a meta-analysisKV Patel, RD Semba, L Ferrucci, AB Newman, LP Fried, RB Wallace, ...Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 20095192009
2-)
Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention TrialYL Qiao, SM Dawsey, F Kamangar, JH Fan, CC Abnet, XD Sun, ...Journal of the National Cancer Institute 101 (7), 507-518, 20093762009
3-)
Comparability of segmented line regression modelsHJ Kim, MP Fay, B Yu, MJ Barrett, EJ FeuerBiometrics 60 (4), 1005-1014, 20042422004
4-)
Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or olderAN Freedman, B Yu, MH Gail, JP Costantino, BI Graubard, VG Vogel, ...Journal of Clinical Oncology 29 (17), 2327, 20112242011
5-)
Bias associated with self-report of prior screening mammographyKA Cronin, DL Miglioretti, M Krapcho, B Yu, BM Geller, PA Carney, ...Cancer Epidemiology and Prevention Biomarkers 18 (6), 1699-1705, 20091542009
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept